Bertin Bioreagent
You are here :
- Bioreagent /
- Search Products /
- Products /
- Applications /
- ELISA /
- VEGF-A (pig) ELISA kit
VEGF-A (pig) ELISA kit
-
Zoom
Cat No: A05426
Assay Kits
- Elisa
Enzyme ImmunoAssay (EIA) is a technique to detect and quantify antigens (proteins, hormones…) or antibodies in samples. It relies on the ability of an antibody to bind a specific antigen. Either the antibody or the antigen is labelled with an enzyme wh...
MoreThis product can not be purchased online. Please contact us
Territorial Availability: Available worldwide directly through Bertin or your local distributor
Technical Warning: Check the Additional Items Required section of this kit booklet to verify if UltraPure Water (Milli-Q or equivalent) is needed for this assay
Synonyms:
- vascular endothelial growth factor
- VEGF
- vascular permeability factor
- VPF
Correlated keywords:
- ELISA
- EIA
- angionesis
- chemotactism
- VEGF
- vascular endothelial growth factor
- vascular permeability factor
- VPF
Product Overview:
Enzyme ImmunoAssay (EIA) is a technique to detect and quantify antigens (proteins, hormones…) or antibodies in samples. It relies on the ability of an antibody to bind a specific antigen. Either the antibody or the antigen is labelled with an enzyme whose substrate is a chromogen or a fluorogen converted in a measurable product (color or fluorescence).
Enzyme-linked Immunosorbent Assay (ELISA) is a type of EIA using a solid phase (ex: microtiter plate) coated with an antigen immobilizing the molecule to detect. Over the time, scientists have extended the term ELISA to EIAs using an antibody coating the solid phase. That explains why our EIA kits using coated antibodies are also called ELISA kits.
Vascular endothelial growth factor (VEGF-A or VEGF)(1), also known as vascular permeability factor (VPF)(2), has been discovered in 1983. It is a member of the VEGF family that includes in mammals placental growth factor (PLGF), VEGF-B, VEGF-C, and VEGF-D (also known as c-Fos-induced growth factor, FIGF)(1).
VEGF-A is a glycoprotein having several isoforms of 121 to 206 amino acids(1) with a molecular weight from 33 kDa to 57kDa. It is a homodimer stabilised by hydrophobic interactions and by a disulphide bound(3). The monomer structure contains a central antiparallel four-stranded β sheet with a cystine knot at the end (4).
VEGF-A is produced by many cells like fetal tissu, hematopoietic stem cells, epidermal keratinocytes, podocytes of the renal glomerulus, cardiac myocytes, prostatic epithelium, and certain epithelial cells of the adrenal cortex and lung(5).
The main function of the VEGF-A is the angionesis (formation of new capillaries from pre-existing vessels) during the embryogenesis(1) or during re-building of the blood vessel after an injury. It has also some secondary functions in the chemotacxis of macrophages/ granulocytes and in vasodilation (indirectly by NO release).
Due to its main function, overexpression of VEGF-A causes various diseases including cancer.
Enzyme ImmunoAssay (EIA) is a technique to detect and quantify antigens (proteins, hormones…) or antibodies in samples. It relies on the ability of an antibody to bind a specific antigen. Either the antibody or the antigen is labelled with an enzyme whose substrate is a chromogen or a fluorogen converted in a measurable product (color or fluorescence).
Enzyme-linked Immunosorbent Assay (ELISA) is a type of EIA using a solid phase (ex: microtiter plate) coated with an antigen immobilizing the molecule to detect. Over the time, scientists have extended the term ELISA to EIAs using an antibody coating the solid phase. That explains why our EIA kits using coated antibodies are also called ELISA kits.
Vascular endothelial growth factor (VEGF-A or VEGF)(1), also known as vascular permeability factor (VPF)(2), has been discovered in 1983. It is a member of the VEGF family that includes in mammals placental growth factor (PLGF), VEGF-B, VEGF-C, and VEGF-D (also known as c-Fos-induced growth factor, FIGF)(1).
VEGF-A is a glycoprotein having several isoforms of 121 to 206 amino acids(1) with a molecular weight from 33 kDa to 57kDa. It is a homodimer stabilised by hydrophobic interactions and by a disulphide bound(3). The monomer structure contains a central antiparallel four-stranded β sheet with a cystine knot at the end (4).
VEGF-A is produced by many cells like fetal tissu, hematopoietic stem cells, epidermal keratinocytes, podocytes of the renal glomerulus, cardiac myocytes, prostatic epithelium, and certain epithelial cells of the adrenal cortex and lung(5).
The main function of the VEGF-A is the angionesis (formation of new capillaries from pre-existing vessels) during the embryogenesis(1) or during re-building of the blood vessel after an injury. It has also some secondary functions in the chemotacxis of macrophages/ granulocytes and in vasodilation (indirectly by NO release).
Due to its main function, overexpression of VEGF-A causes various diseases including cancer.
| Size | 96 wells |
| Shipping | wet ice |
| Specificity | |
| Application Media | It is the responsibility of the user to check the compatibility of the assay with the study matrix |
| Sample volume | 100 µL |
| Tracer | horseradish peroxidase HRP |
| Detection Limit | ≤0,01 ng/mL |
| Standard Curve Range | 0,01-1,00 ng/mL |
| Custom Code | 3822000000 |
| UNSPSC code | 41116104 |
1. David IR Holmes and Ian Zachary The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease 2005, Genome Biology, 6 :209
2. Angela M. Duffy, David J. Bouchier-Hayes, and Judith H. Harmey Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF 2000-2013, Madame Curie Bioscience Database
3. Christopher J. Robinson and Sally E. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors Journal of Cell Science 114, 853-865
4. Yves A Muller, Hans W Christinger, Bruce A Keyt, Abraham M de Vos The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding 1997, Structure Volume 5, Issue 10, 1325-1338
5. Dvorak HF, Brown LF, Detmar M, Dvorak AM Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. 1995, Am J Pathol, 146:1029-1039
Follow Us
Contact us
Any project? Any challenge? We are in!
+33 (0)139 306 036
Any questions?
Contact us
Headquarters :
Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
View our other locations
Bertin Bioreagent
Copyright © Bertin Bioreagent - All rights reserved
Made by 
Loading...